Methodology Change | Solactive Global Uranium Pure Play Index | Effective Date 05/01/2023

Today, on the 22/12/2022, Solactive announces the following changes to the methodology of the following indices (the ‘Affected Indices’):

Rationale for Methodology Change

To enhance the scope of Pure Play- and Uranium Participation Companies as currently reflected in the methodology, Solactive decided to add investment trust to the below mentioned Definitions in Sections 4. Even though not structured as a company, trusts which invests primarily in physical uranium would meet the existing index definition from an exposure perspective.  

Changes to the Index Guideline

Section 4 Definitions:

From:

[…]

“Pure Player” refers to a company where a significant part of the business operations is or is expected to be related to the uranium industry (in particular uranium mining, exploration for uranium, physical uranium investments and technologies related to the uranium industry). Furthermore, companies with an investment focus on the uranium sector are also considered as pure players.

[…]

“Uranium Participation Company” refers to a company that invest directly in assets in uranium, either in the form of uranium oxide in concentrates (‘U3O8’) or uranium hexafluoride (‘UF6’) (collectively ‘uranium’), with the primary investment objective of achieving appreciation in the value of its uranium holdings.

[…]

To:

[…]

“Pure Play Company” refers to a company where a significant part of the business operations is or is expected to be related to the uranium industry (in particular uranium mining, exploration for uranium, physical uranium investments and technologies related to the uranium industry). Furthermore, companies with an investment focus on the uranium sector or investment trusts whose primary purpose is to provide exposure to physical uranium are also considered as pure players.

[…]

“Uranium Participation Company” refers to a company or investment trust that invests directly in assets in uranium, either in the form of uranium oxide in concentrates (‘U3O8’) or uranium hexafluoride (‘UF6’) (collectively ‘uranium’), with the primary investment objective of achieving appreciation in the value of its uranium holdings.

[…]

Defined terms used in this announcement, but not defined herein, have the meaning assigned to them in the respective index guideline of the Affected Indices.